BRIEF-Zealand Pharma Initiates Global Phase 3 ZUPREME Program For Petrelintide

2

Sept 22 (Reuters) – Zealand Pharma A/S: * INITIATES GLOBAL PHASE 3 ZUPREME PROGRAM FOR PETRELINTIDE * PHASE 3A ZUPREME PROGRAM CONSISTS OF THREE TRIALS FOR PETRELINTIDE MONOTHERAPY * PRIMARY ENDPOINT

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)